News Related to Early-Stage Lung Cancer

Related coverage linked through entity extraction aliases.

Experimental Cancer Drugs Show Promise in Prostate and Lung Cancer Trials

Mar 25, 2026

An experimental immunotherapy drug shows tumor shrinkage in prostate cancer patients, while Eli Lilly's selpercatinib reduces recurrence risk in early-stage lung cancer. A separate study reveals persistent racial disparities in curative treatment for lung cancer patients.

Eli Lilly Builds $1.5 Billion Inventory Ahead of Oral Weight-Loss Drug Launch

Feb 16, 2026

Eli Lilly has stockpiled $1.5 billion in inventory for Orforglipron ahead of an expected FDA decision in April. The oral weight-loss pill aims to compete with Novo Nordisk's recently approved oral Wegovy.